GlassScriptPhysician profile
Shaun Gabriel
NPI 1962666701
$19,367.39
in general payments reported to CMS, 2019-2025
36 companies · $4,338 in 2025
The $4,338 reported for 2025 was more than what 89% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,562 · 2020: $1,248 · 2021: $1,530 · 2022: $2,537 · 2023: $3,938 · 2024: $1,216 · 2025: $4,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,851 · Travel and Lodging: $2,634 · Education: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,851.30 |
| Travel and Lodging | $2,634.43 |
| Education | $1,005.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $8,941.16 | 2019-2024 | Senza |
| Abbott Laboratories | $3,015.16 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $1,610.06 | 2021-2023 | Intellis Adaptivestim |
| Abbvie INC. | $732.19 | 2021-2025 | |
| Boston Scientific Corporation | $694.80 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Angiojet Ultra 5000a |
| Mml US, INC. | $675.16 | 2025 | Reactiv8 |
| Globus Medical, INC. | $593.30 | 2025 | Senza, Vyrsa V1 |
| Spr Therapeutics, INC | $511.31 | 2021-2024 | Sprint Pns System |
| Stryker Corporation | $408.50 | 2025 | Mild Device Kit, Spinejack, Optablate |
| Allergan, INC. | $288.52 | 2020-2022 | |
| Saluda Medical Americas, INC. | $229.00 | 2025 | Evoke |
| Stimwave Technologies Incorporated | $207.66 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $165.68 | 2021 | |
| Bioventus LLC | $153.05 | 2019-2024 | Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Nalu Medical, INC. | $149.03 | 2025 | Nalu Neurostimulation System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $143.36 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $140.27 | 2022 | |
| Nuvasive, INC. | $83.74 | 2023 | Acp |
| Enterra Medical, INC. | $73.88 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.29 | 2021 | |
| Fidia Pharma USA INC. | $55.57 | 2020-2022 | |
| Si-Bone, INC. | $53.95 | 2019 | |
| Zynex Medical, INC. | $52.34 | 2025 | Nexwave |
| Biodelivery Sciences International, INC. | $45.02 | 2020-2021 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $29.33 | 2019 | |
| Grt US Holding, INC. | $27.84 | 2021 | |
| Uswm, LLC | $27.21 | 2021 | |
| Mdd US Operations, LLC | $26.76 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $25.99 | 2025 | |
| Depuy Synthes Sales INC. | $25.60 | 2024 | Monovisc |
| Avanos Medical | $23.70 | 2020 | |
| Assertio Therapeutics, INC. | $19.08 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.29 | 2024 | Xtampza |
| Pacira Therapeutics, INC. | $16.59 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Gabriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.